217 related articles for article (PubMed ID: 31149050)
1. SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.
Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
Tian J; Yuan L
Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
[TBL] [Abstract][Full Text] [Related]
3. Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis.
Sun L; Huang Y; Liu Y; Zhao Y; He X; Zhang L; Wang F; Zhang Y
Cell Death Dis; 2018 Sep; 9(9):911. PubMed ID: 30185800
[TBL] [Abstract][Full Text] [Related]
4. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.
Dong Z; Yang J; Li L; Tan L; Shi P; Zhang J; Zhong X; Ge L; Wu Z; Cui H
Int J Oncol; 2020 Mar; 56(3):728-742. PubMed ID: 32124950
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract][Full Text] [Related]
6. Oleanolic acid induces HCT116 colon cancer cell death through the p38/FOXO3a/Sirt6 pathway.
Potočnjak I; Šimić L; Vukelić I; Batičić L; Domitrović R
Chem Biol Interact; 2022 Aug; 363():110010. PubMed ID: 35690101
[TBL] [Abstract][Full Text] [Related]
7. MST1 suppresses viability and promotes apoptosis of glioma cells via upregulating SIRT6 expression.
Zhu D; Sun C; Qian X
J Integr Neurosci; 2019 Jun; 18(2):117-126. PubMed ID: 31321952
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells.
Dong Z; Zhong X; Lei Q; Chen F; Cui H
Cell Signal; 2019 Aug; 60():100-113. PubMed ID: 31004738
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D
Shang J; Zhu Z; Chen Y; Song J; Huang Y; Song K; Zhong J; Xu X; Wei J; Wang C; Cui L; Liu CY; Zhang J
Theranostics; 2020; 10(13):5845-5864. PubMed ID: 32483423
[TBL] [Abstract][Full Text] [Related]
10. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
11. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
[TBL] [Abstract][Full Text] [Related]
12. FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation.
Wang X; Ji T; Li X; Qu X; Bai S
Oxid Med Cell Longev; 2021; 2021():5565761. PubMed ID: 34122724
[TBL] [Abstract][Full Text] [Related]
13. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine-induced nuclear translocation of the FOXO3A transcription factor triggers BIM-mediated apoptosis in cancer cells.
Liu Z; Shi Z; Lin J; Zhao S; Hao M; Xu J; Li Y; Zhao Q; Tao L; Diao A
Biochem Pharmacol; 2019 May; 163():101-110. PubMed ID: 30753811
[TBL] [Abstract][Full Text] [Related]
15. Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis.
Zhang L; Wang H; Li W; Zhong J; Yu R; Huang X; Wang H; Tan Z; Wang J; Zhang Y
Oncotarget; 2017 Jan; 8(2):3289-3303. PubMed ID: 27924057
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth.
Zhang Y; Zhang C; Li J; Jiang M; Guo S; Yang G; Zhang L; Wang F; Yi S; Wang J; Fu Y; Zhang Y
Cell Commun Signal; 2022 Jun; 20(1):93. PubMed ID: 35715817
[TBL] [Abstract][Full Text] [Related]
17. Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer.
Liu J; Duan Z; Guo W; Zeng L; Wu Y; Chen Y; Tai F; Wang Y; Lin Y; Zhang Q; He Y; Deng J; Stewart RL; Wang C; Lin PC; Ghaffari S; Evers BM; Liu S; Zhou MM; Zhou BP; Shi J
Nat Commun; 2018 Dec; 9(1):5200. PubMed ID: 30518851
[TBL] [Abstract][Full Text] [Related]
18. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
19. Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARγ/SIRT6/FoxO3a pathway after subarachnoid hemorrhage in rats.
Zuo Y; Huang L; Enkhjargal B; Xu W; Umut O; Travis ZD; Zhang G; Tang J; Liu F; Zhang JH
J Neuroinflammation; 2019 Feb; 16(1):47. PubMed ID: 30791908
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism.
Sebastián C; Zwaans BM; Silberman DM; Gymrek M; Goren A; Zhong L; Ram O; Truelove J; Guimaraes AR; Toiber D; Cosentino C; Greenson JK; MacDonald AI; McGlynn L; Maxwell F; Edwards J; Giacosa S; Guccione E; Weissleder R; Bernstein BE; Regev A; Shiels PG; Lombard DB; Mostoslavsky R
Cell; 2012 Dec; 151(6):1185-99. PubMed ID: 23217706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]